Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07226557

Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation

Sponsor: National Institutes of Health Clinical Center (CC)

View on ClinicalTrials.gov

Summary

This study aims to compare 28-day mortality among patients with carbapenem resistant A. baumannii infections in two hypothetical target trials where patients receive 7 days of a cefiderocol-based treatment strategy or 7 days of a best available therapy treatment strategy.

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

OBSERVATIONAL

Enrollment

5000

Start Date

2025-01-01

Completion Date

2025-12-31

Last Updated

2025-11-10

Healthy Volunteers

No

Locations (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States